• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
FLGT

FLGT

Fulgent Genetics, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD18.14

-0.56 (-2.99%)

Rating:B-

Company Profile

CEO

Ming Hsieh

IPO Date

2016-09-29

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$18.60

Prev. Close

$18.70

Day Low

$18.08

Day High

$19.14

52W Low

$13.46

52W High

$31.04

Market Cap

$0.52B

Volume

0.70M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

40.0%

Avg Negative

14.8%

Avg Neutral

45.0%

News Feed

CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021

Business Wire·7/26/2021·↑ positive

FULGENT GENETIC (FLGT) Stock Moves -0.13%: What You Should Know

Zacks Investment Research·7/8/2021·↑ positive

Is It Too Late to Buy Fulgent Genetics Stock?

The Motley Fool·6/29/2021·↑ positive

3 Reasons I Just Bought Fulgent Genetics Stock

The Motley Fool·6/24/2021·↑ positive

Revisiting a Top Contrarian Stock Pick of 2021

Schaeffers Research·6/17/2021·↑ positive

Fulgent Genetics: Get In Early Before It Starts To Take Off

Seeking Alpha·6/13/2021·↑ positive

How Long Will Fulgent Genetics Benefit From the Pandemic?

The Motley Fool·5/29/2021·↑ positive

What Are Investors Thinking About Fulgent Genetics?

The Motley Fool·5/14/2021·↓ negative

Fulgent Genetics Has Another Blast Out Quarter

Seeking Alpha·5/12/2021·↑ positive

Fulgent Genetics: How Cash Could Be Deployed And Underlying Implications

Seeking Alpha·5/10/2021·↓ negative